Asymmetry analysis of macular optical coherence tomography angiography in patients with glaucoma and healthy subjects
- PMID: 32107207
- DOI: 10.1136/bjophthalmol-2019-315592
Asymmetry analysis of macular optical coherence tomography angiography in patients with glaucoma and healthy subjects
Abstract
Background/aims: Quantitative analysis of optical coherence tomography angiography (OCT-A) images requires a reproducible approach that accounts for sectoral loss. The objective of this study was to determine whether an index that accounts for both global (perfusion density, PD) and asymmetric loss of perfusion, rather than PD alone, more reliably measures loss of perfusion in patients with glaucoma.
Methods: We analysed macular OCT-A scans of 95 glaucoma patients and 59 control subjects. Two-dimensional projection images corresponding to the superficial vascular plexus were exported and analyses performed to calculate global PD and image asymmetry. An unsigned perfusion asymmetry index (PAI) that included PD and asymmetry (with 1:1 wt) was calculated. Perfusion density and PAI were compared with 10-2 visual field mean deviation and ganglion cell layer (GCL) thickness.
Results: Median (IQR) visual field mean deviation was -1.73 (-3.76, 0.30) dB for the glaucoma group and 0.67 (0.16, 1.18) dB for the control group. The strength of the correlation with mean deviation was stronger for PAI (r=0.47), compared with PD (r=0.35), whereas with GCL thickness they were comparable (r=0.45 and 0.43, respectively). Compared with controls, mean PD was 12% lower in patients with glaucoma (0.27 vs 0.30), while PAI was 17% lower (0.40 vs 0.48). However, diagnostic accuracy of either PD or PAI was worse than GCL thickness.
Conclusions: While PAI yielded better correlation with mean deviation and GCL thickness, and a slightly improved separation between patients with glaucoma and healthy controls, diagnostic accuracy was inferior compared with GCL thickness.
Keywords: glaucoma; imaging; macula.
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: LMS: Consultant—Alcon, Allergan, Bausch and Lomb, Thea Pharmaceuticals. PER: Consultant—Allergan, Bausch and Lomb; Lecturer—Bausch and Lomb. MTN: Consultant and Lecturer—Allergan, Alcon. BCC: Equipment support—CenterVue, Heidelberg Engineering, Topcon; Lecturer—Santen.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous